Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerative Colitis for Up to One Year in Phase 2 Study ...Middle East

INDIANAPOLIS, July 9, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced new Phase 2 data showing that gene expression changes induced by mirikizumab in patients with ulcerative colitis (UC) over a 12-week induction treatment were maintained for up to one year. These gene...

Hence then, the article about mirikizumab up regulates genes associated with mucosal healing in ulcerative colitis for up to one year in phase 2 study was published today ( Friday 09/07/2021 - 02:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerative Colitis for Up to One Year in Phase 2 Study )

Also on site :

• Heavy police presence in NW suburb with roads blocked due to ‘isolated incident'
• The top pandemic threats as WHO declares Ebola emergency
• Starbucks Expands Its Summer Menu With 2 Vibrant New Drinks